^
Association details:
Biomarker:ER positive
Cancer:Male Breast Cancer
Drug:tamoxifen (Estrogen receptor antagonist)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Title:

4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

Published date:
07/19/2018
Excerpt:
For ER-positive male ABC tamoxifen is the preferred option.
DOI:
10.1093/annonc/mdy192